# US 2026/0092335 A1 · Virus nucleic acid sample diluent, virus nucleic acid sample extraction kit, and virus nucleic acid extraction method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0092335 A1
- Document ID: US20260092335A1
- Status: Published application
- Kind: A1
- Application number: 19/113,562
- Filed: 2022-12-30
- Published: 2026-04-02
- Earliest claimed: 2022-09-27
- Assignees: Shanghai Biogerm Medical Technology Co., Ltd.
- Applicants: Shanghai Biogerm Medical Technology Co., Ltd.
- Inventors: Ziming SHEN; Baihui ZHAO; Chunyan LI; Chunlei ZHANG
- Web page: https://patentgrep.com/patent/US20260092335A1

## CPC

- C12Q 1/70: involving virus or bacteriophage {(immunoassay for viruses G01N33/56983)}
- C12N 15/1003: {Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/701: {Specific hybridization probes}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A virus nucleic acid sample diluent, sample extraction kit, and extraction method. A release agent compatible with various sampling sets. Critical micelle concentration of a used surfactant is reduced by adjusting types and proportions of components. The lysis of a cell and a pathogen can be ensured, and the inhibitory effect on subsequent detection systems can be reduced. Under the condition that an ion exchange resin is added, a protein and metal ions (e.g., calcium and magnesium ions) that affect a subsequent reaction can be adsorbed from a sample, and cell and virus lysis can also be promoted, for enhanced compatibility of the system. Compatible with various Quantitative polymerase chain reaction (qPCR) detection systems at the same time, and can also be used for an isothermal recombinase-aided amplification (RAA) amplification system. Suitable for a liquid detection system and a dry powder detection system with a large sample volume.

## Claims

### Claim 1

A viral nucleic acid sample diluent, comprising: an anionic surfactant, sodium hydroxide, EDTA, trehalose, and an ion exchange resin, wherein an addition amount of the EDTA is 0-3% according to mass-volume ratio; an addition amount of the anionic surfactant is 0.010%-0.050%; and an addition amount of the ion exchange resin is 0-5%.

### Claim 2 (depends on 1)

The viral nucleic acid sample diluent according to claim 1, wherein the anionic surfactant is selected from sodium dodecyl sulfate, sodium tetradecyl sulfate, sodium hexadecyl sulfate, and sodium octadecyl sulfate.

### Claim 3 (depends on 1)

The viral nucleic acid sample diluent according to claim 1, wherein a concentration of the sodium hydroxide is 0.16-1.28 mmol/L.

### Claim 4 (depends on 1)

The viral nucleic acid sample diluent according to claim 1, further comprising one or a combination of two or more of polyol, sodium chloride, or NP-40.

### Claim 5 (depends on 4)

The viral nucleic acid sample diluent according to claim 4, wherein the polyol is selected from ethylene glycol and propylene glycol:
wherein the polyol is 0-10% propylene glycol according to mass-volume ratio;
wherein a concentration of the NP-40 is 1%-5% according to mass-volume ratio;
wherein a concentration of the sodium chloride is 50-150 mmol/L.

### Claim 6 (depends on 1)

The viral nucleic acid sample diluent according to claim 1, wherein the ion exchange resin is selected from chelex and bio-rex 70, and the chelex has a specification of 50-400 mesh.

### Claim 7 (depends on 1)

The viral nucleic acid sample diluent according to claim 1, wherein a concentration of the trehalose is 0.05-0.1 mmol/L.

### Claim 8 (depends on 1)

A kit for extracting viral nucleic acid from samples, comprising the viral nucleic acid sample diluent according to claim 1.

### Claim 9 (depends on 1)

A method for extracting viral nucleic acid from samples, comprising: uniformly mixing a virus sample with the viral nucleic acid sample diluent according to claim 1, and obtaining the viral nucleic acid after completing the reaction.

### Claim 10 (depends on 9)

The method for extracting viral nucleic acid from samples according to claim 9, wherein the method for extracting viral nucleic acid from samples comprises the following steps: uniformly mixing the virus sample with the viral nucleic acid sample diluent, and then heating, and obtaining the viral nucleic acid after completing the reaction:
wherein the heating is performed at a temperature of 90-110° C., with a period of 1-5 min.

### Claim at position 11

-12. (canceled)

### Claim 13 (depends on 1)

A method for diagnosing a disease associated with a virus infection in a subject, comprising:
A) uniformly mixing the viral nucleic acid sample diluent according to claim 1 with a virus sample from the subject, obtaining a viral nucleic acid after completing the reaction, and performing a detection via a virus detection reagent; and
B) determining the source of the virus.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the virus comprises a novel coronavirus.

### Claim 15 (depends on 1)

The viral nucleic acid sample diluent according to claim 1, wherein an addition amount of the EDTA is 1%; an addition amount of the anionic surfactant is 0.02%; and an addition amount of the ion exchange resin is 2.5%.

### Claim 16 (depends on 1)

The viral nucleic acid sample diluent according to claim 1, wherein the anionic surfactant is selected from sodium hexadecyl sulfate.

### Claim 17 (depends on 1)

The viral nucleic acid sample diluent according to claim 1, wherein a concentration of the sodium hydroxide is 0.32 mmol/L.

### Claim 18 (depends on 5)

The viral nucleic acid sample diluent according to claim 5, wherein the polyol is 5% propylene glycol according to mass-volume ratio:
wherein a concentration of the NP-40 is 1% according to mass-volume ratio;
wherein a concentration of the sodium chloride is 100 mmol/L.

### Claim 19 (depends on 1)

The viral nucleic acid sample diluent according to claim 1, wherein the ion exchange resin is bio-rex 70.

### Claim 20 (depends on 1)

The viral nucleic acid sample diluent according to claim 1, wherein a concentration of the trehalose is 0.075 mmol/L.

### Claim 21 (depends on 8)

The kit for extracting viral nucleic acid from samples according to claim 8, wherein the viral nucleic acid sample extraction kit comprises a heating device.

### Claim 22 (depends on 9)

The method for extracting viral nucleic acid from samples according to claim 9, wherein the reaction is performed for a period of 5-15 min.
